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Abstract 
Background: It is believed that, in resource poor countries like Ethiopia the survival of patients 
with AIDS treated with ART depends on a variety of factors, which may also vary greatly with 
economic, demographic, risk behavioral and clinical factors. Understanding the survival time and 
its patterns is the key for policy formulation in bringing improvements. The aim of this study 
was to compare the survival estimates of different subgroups, and investigating the predictors of 
survival of cohort of HIV/AIDS patients.  
Methods: A retrospective cohort study of AIDS patients aged 15 years or more followed-up 
under ART at University of Gondar Hospital was conducted. We used survival analysis of 
Kaplan-Meier plots for survival curve comparisons. Finally, the Cox proportional hazards model 
was employed to investigate the determinant covariates of survival experience of AIDS patients.  
Results: This study cohort comprised of 354 AIDS patients under ART follow-up. Of the 
patients, 5.91% were uncensored or death cases. Covariates or factors associated with lower 
survival were age (HR = 1.051) and no formal education (HR = 5.032) while covariates or 
factors associated with longer survival were family size of 1 to 2 (HR = 0.167), three to four (HR 
= 0.120), no alcoholic consumption (HR = 0.294), no tobacco and chat use (HR = 0.101), 
baseline weight (HR = 0.920), current weight (HR = 0.928), baseline CD4 cell count (HR = 
0.990), baseline hemoglobin (HR = .800) and negative/no TB status (HR = 0.145).  
Conclusions: As there was good adherence level of patients in the study area, fewer death cases 
were reported as compared to previous similar studies. The covariates age, educational status, 
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family size, alcohol consumption, tobacco and chat usage, baseline and current weight, baseline 
CD4 cell count, baseline hemoglobin and TB status were significant predictors of survival.  
Keywords: HIV/AIDS, ART, Survival analysis, Cox proportional hazards model  
1. Introduction 
Acquired Immune Deficiency Syndrome (AIDS) which is believed to be caused by the Human 
Immunodeficiency Virus (HIV) has been the major problem for the past three decades 
worldwide. HIV infection is one of the most prevalent infectious diseases in the world, affecting 
more than 35 million people globally (1). During these years HIV infection has changed from a 
fatal condition to a manageable chronic illness mainly due to the development of antiretroviral 
therapy (ART). The goal of this therapy is to improve survival; to reduce HIV associated 
morbidity and mortality, to increase the quality of life, to restore immune function and to achieve 
maximal and sustained suppression of viral replication (2). 
Knowledge of the survival times of patients with AIDS and variables that influence survival are 
important both for increasing understanding of the patho-physiology of the disease, clinical 
decision making and planning health service interventions (3). The main challenge here is the 
sustainability of providing ART and other medications at district hospitals.  
About one million people were living with HIV in Ethiopia in the year 2008 (4). Survival 
patterns following HIV infection in African populations in the era before antiretroviral therapy 
(ART) form an important baseline for measuring future successes of treatment programs (5). 
Despite the availability of a large body of research evidence that addresses issues about AIDS in 
Ethiopia, the level of understanding about predictor variables associated with survival experience 
of HIV patients is low (6).  
The study had discovered the mathematical model with a focus on survival models in predicting 
the probability of survival of patients and identifying the factors associated with survival time of 
AIDS patients. 
Statement of the Problem  
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Although the current HIV/AIDS surveillance estimates indicate some encouraging signs in that 
the epidemic is stabilizing, the observed changes are not sufficient enough compared to the 
desired goals of the response against the epidemic. It is believed that, in resource poor countries 
like Ethiopia the survival of patients with AIDS treated with ART depends on a variety of 
factors, which may also vary greatly with economic, demographic, behavioral risk and health 
factors. In other words, even if ARV treatment has shown significant clinical importance by 
meeting the goal of therapy, we are still facing a number of deaths that can otherwise be avoided 
by appropriate interventions on certain socio-economic, demographic, behavioral risk and health 
factors.  
The performance of ART programs can be improved if we can bring behavioral change among 
HIV patients under ART follow up, take appropriate clinical and non-clinical measures like 
providing medicine and support to patients. Therefore, this study is motivated to investigate the 
major factors of survival time of AIDS patients. The questions we want to address here are:  
1. What is the mean survival time of HIV/AIDS patients?  
2. Which factors have significant (major) effect on the survival of HIV/AIDS patients?  
Objectives of the Study  
General objective:  
The general objective of this study was to model and identify the associated factors of survival 
time of HIV/AIDS patients.  
Specific objectives:  
 To pronounce the survival experience of HIV/AIDS patients  
 To estimate and compare survival probabilities with a given time of AIDS patients 
groups.  
 To identify the major factors that may affect survival of AIDS patients.  
 To develop a statistical model that can predict the probability of survival of AIDS 
patients.  
 To provide scientific information on the results obtained to policy makers and future 
researchers.  
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2. Methods 
2.1. Study Design 
A retrospective study design was employed on of people living with AIDS and followed-up 
under ART at University of Gondar Hospital, Gondar, Ethiopia. All patients under ART follow-
up between September 2009 and March 2015 were considered as a target population. At ART 
follow-up database, a total of 3397 AIDS adult (greater than 14 years) patients were registered. 
2.2. Sample Size Determination 
We had applied the following simple rand sampling equation (7) to determine the size of the 
participants to be included in the study.  
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where Z is the upper α/2 points of standard normal distribution with significance level, which is 
Z = 1.96. d = 3.36% is the degree of precision that mostly selected by the investigator. The term 
p represents proportion of death among HIV/AIDS patients. The proportion of death р that was 
selected for this study was obtained from the previous comparable study done by (8) on data 
taken from Felege-Hiwot referral hospital which is 13.4%. Therefore, in this study, a sample of 
354 adult patients’ chart review was conducted using the above equation.  
2.3. Variables 
AIDS survival time was estimated from the date of AIDS diagnosis to the date of AIDS-related 
death or censoring date (in months). And we have used demographic, clinical and risk behavior 
factors to measure the survival experience of AIDS patients.  
2.4. Data Analysis 
We have used a number of data analysis techniques. Descriptive measures were conducted to 
explore the proportion of patients lay in different subgroups of each variable, and to know the 
mean survival time of patients in this subgroups. We used Kaplan-Meier survival estimates or 
curves to compare the survival time estimate of patients under different classifications. And 
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finally, the Cox proportional hazards model was employed to measure the estimated hazard of 
death of patients and to identify the factors associated with the survival experience of AIDS 
patients. Actually, the data was analyzed using SPSS and STATA software packages.  
3. Ethical Issues 
This study had already obtained ethical approval by the research Ethics Committee of University 
of Gondar, Ethiopia. In addition, the University of Gondar Hospital Medical director office 
permitted the use of patients’ data for this study. 
4. Results 
4.1. HIV/AIDS Patients Demographic Information 
Information on demographic characteristics, and clinical and risk behavior factors of HIV/AIDS 
patients under ART follow-up were collected in their follow-up charts. In this study, a sample 
total of 354 HIV/AIDS patients were considered. Out of which 5.93% (21) death cases occurred, 
and 94.07% (336) were censored. As we see from Table 1 below, most of the patients 
(211(59.6%)) were female while the remaining (40.4%) were male. Almost all of the study 
subjects live in urban areas but small patients (13.6%) reside in rural places. According to the 
patients’ marital status information or figure, 162 (45.8%), 90(25.4), 76(21.5) and 26(7.3%) were 
married, separated/divorced, single and widowed, respectively. 
From 354 patients under follow up, very large numbers of patients (320) were followers 
orthodox religion where as 29 and 5 patients were Muslim and other religion followers, 
respectively. Of the total study participants, 201(56.8) patients had a family size between one to 
two person/s. Patients without formal education took 26.3% of the total sample, while those 
whose educational status were primary, and secondary and above covered 28.5 and 45.2%, 
respectively.  
Table 1: Summary Results for Socio-demographic Composition of HIV/AIDS Patients Treated 
under ART Follow-up (University of Gondar Hospital, 2009 - 2015) 
Variables Frequency Percent 
Sex  
Female 211 59.6 
Male 143 40.4 
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Residence 
Urban 306 86.4 
Rural 48 13.6 
Marital Status 
Single 76 21.5 
Married 162 45.8 
Separated/Divorced 90 25.4 
Widowed 26 7.3 
Religion 
Orthodox 320 90.4 
Muslim 29 8.2 
Other 5 1.4 
Family Size 
1-2 201 56.8 
3-4 91 25.7 
>=5 62 17.5 
Educational Status 
No formal education 93 26.3 
Primary 101 28.5 
Secondary and above 160 45.2 
4.2. HIV/AIDS Patients Clinical and Risk Behavior Descriptive Information 
The study revealed that 63.6% of HIV/AIDS patients under ART follow-up consumed alcohol, 
and the remaining (36.4) did not consumed (Table 2). As shown in Table 2, only few patients  
(10.7%) used tobacco and chat. Almost all of the patients (94.4) disclosed their HIV infectivity. 
Of the patients in the study, 86.4%, 11.3% and 2.3% were under working, ambulatory and 
bedridden status, respectively. 96.1% of the total patients in the study were with good ART 
adherence level while 2.8% and 1.1% of the patients’ adherence level were poor and fair 
respectively. Patients TB history indicated that 332 (93.8%) had not faced TB infection where as 
few figures (22) infected with TB (Table 2.  
Table 2: Summarized Information on HIV/AIDS Patients’ Clinical and Risk Behavior Factors 
under ART (University of Gondar Hospital, 2009 - 2015) 
Variables Frequency Percent 
Alcohol Consumption 
No 225 63.6 
Yes 129 36.4 
Tobacco and chat use No 316 89.3 
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Yes 38 10.7 
HIV disclosure Status 
Not disclosed 20 5.6 
Disclosed 334 94.4 
Functional Status 
Bedridden 8 2.3 
Ambulatory 40 11.3 
Working 306 86.4 
ART Adherence level 
Poor 10 2.8 
Fair 4 1.1 
Good 340 96.1 
TB_History 
No 332 93.8 
Yes 22 6.2 
The average age of 354 HIV/AIDS patients followed-up under ART was 34.8 years (Table 3). 
The patients in the study had an average baseline weight of 51.2 kg, and their mean current 
weight was about 54.8 kg. The average baseline CD4 cell count of HIV/AIDS patients in the 
study was around 183.6 cells/µl. The mean baseline lymphocyte count and baseline hemoglobin 
for the 354 patients were reported as 33.1 cells/mm
3
 and 13.2 g/dl, respectively (Table 3).  
Table 3: Description of Continuous Covariates/Measures of 354 HIV/AIDS Patients under the    
Study (University of Gondar Hospital, 2009 - 2015)    
Variables Minimum Maximum Mean 
Std. 
Deviation 
Age 16.00 70.00 34.7740 9.54665 
Baseline weight 15.00 80.00 51.2062 9.81103 
Current weight 28.00 92.00 54.7994 10.57320 
Baseline CD4 cell count 11.30 1022.00 183.5800 118.58572 
Baseline lymphocyte count 1.10 317.00 33.1274 19.42361 
Baseline hemoglobin 5.00 36.40 13.2435 3.61894 
4.3. Survival Time Comparison 
Number of death cases in each covariate, mean and median survival times, and test of equality of 
survival distributions for the different levels of variables were all presented in Table 4. In the 
study subjects, 19 female and 2 male deaths were registered. The mean survival time of urban 
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and rural patients were 104.9 and 82.3 months, respectively. Patients having 1 to 2 family size 
had highest mean survival time as compared to those having three to four and more than five 
family size (Table 4).  The median survival time of patient who used tobacco and chat was 73.8 
months.  
Survival functions among the subgroups of each covariate were compared by the log rank test. 
The subgroups/levels in the variables: sex, marital status, family size, educational status, alcohol 
consumption, tobacco and chat use, HIV disclosure status, functional status and TB history were 
different in their survival distribution (p-value < 0.05, Table 4). But there was no survival 
distribution difference between the levels on each of the covariates residence, religion and ART 
adherence level (p-value > 0.05).   
Table 4: Survival Time by Potential Demographic, Clinical and Risk Variable for HIV/AIDS 
Patients Treated under ART (University of Gondar Hospital, 2009 - 2015)    
Variable 
Number 
of 
Patients 
Number 
of 
Deaths 
Mean 
Survival 
Time 
Median 
Survival 
Time 
p-value 
Sex  
Female 211 19 99.893 - 
0.004 
Male 143 2 104.548 - 
Residence 
Urban 306 19 104.856 - 
0.896 
Rural 48 2 82.279 - 
Marital 
Status 
Single 76 11 86.732 - 
0.000 
Married 162 4 101.391 - 
Separated/Divorced 90 2 105.998 - 
Widowed 26 4 86.761 - 
Religion 
Orthodox 320 18 - - 
0.592 Muslim 29 3 - - 
Other 5 0 - - 
Family Size 
1-2 201 8 108.070 - 
0.001 3-4 91 3 100.170 - 
>=5 62 10 82.682 - 
Educational 
Status 
No formal education 93 13 94.794 - 
0.019 
Primary 101 5 96.924 - 
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Secondary and 
above 
160 3 106.474 - 
Alcohol 
Consumption 
No 225 9 107.231 - 
0.018 
Yes 129 12 92.048 - 
Tobacco and 
chat use 
No 316 14 106.865 - 
0.000 
Yes 38 7 62.160 73.80 
HIV 
disclosure 
Status 
Not disclosed 20 3 85.811 - 
0.028 Disclosed 
334 18 104.747 - 
Functional 
Status 
Bedridden 8 1 66.847 - 
0.008 Ambulatory 40 6 67.033 73.800 
Working 306 14 106.592 - 
ART 
Adherence 
level 
Poor 10 2 - - 
0.147 Fair 4 0 - - 
Good 340 19 - - 
TB_History 
No 332 16 105.650 - 
0.000 
Yes 22 5 52.348 - 
The survival and hazard functions of HIV/AIDS patients followed-up under ART were presented 
in Figure 1 (a) and (b), respectively. Patients followed up for more than 75 months had 0.85 
probability of survival (Figure 1 (a)). The hazard of death for higher survival months was 
increased (Figure 1(b)). After 75 months of follow up, patients had a constant probability of 
death (0.15). 
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Figure 1: Estimated Survival Function (a) and Hazard Function (b) of HIV/AIDS Patients 
 
Figure 2 presented the survival curve comparison of different subgroups/levels of covariates of 
HIV/AIDS patients under ART follow-up. The Kaplan-Meier survival function indicated that 
patients with five or more family members had lower survival experience than lower family 
sized patients as follow-up time increased (Figure 1(a)). Educational status determined the 
survival status of HIV patients. Patients having secondary and above educational status had 
slightly better survival chance for longer survival times (Figure 1(b)).  The Kaplan-Meier 
survival plot also indicated that patients who consumed alcohol and used chat and tobacco had 
lower survival probability with increased survival time (Figure 1(a), (b)).   
    
   
Figure 2: Comparison of Survival Curves for Different Subgroups of Each Covariate. 
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4.4. The Hazard of Death in HIV/AIDS Patients 
Table 5 described all covariates which had significant association with the survival time of HIV 
patients, and their hazard of death. The variables age, family size, educational status, alcohol 
consumption, tobacco and chat usage, baseline weight, current weight, baseline CD4 cell count, 
baseline lymphocyte count, baseline hemoglobin and TB history were significantly associated 
with survival time of HIV patients under ART fellow-up (p-value < 0.05).  
Thus, one can interpret the effects of each covariate using the estimated hazard ratio (HR) given 
in Table 5. Age had a significant effect on the survival time of HIV patients (HR =1.051, 95% 
CI: 1.002, 1.101). For a year increase, the hazard of death of HIV/AIDS patient was increased by 
5.1%.  
Table 5: The Hazard Estimates of Covariates Associated with the Survival Time of HIV/AIDS 
Patients under ART Follow-up (University of Gondar Hospital, 2009 - 2015)    
Predictor Variables B SE Wald df Sig. AHR 
95.0% CI for HR 
Lower Upper 
Age .049 .024 4.228 1 .040
* 
1.051 1.002 1.101 
Family Size 
> = 5 (ref) 
  
9.854 2 .007
*
 
   
1 - 2 -1.791 .604 8.785 1 .003
*
 .167 .051 .545 
3 - 4 -2.120 .852 6.197 1 .013
*
 .120 .023 .637 
Educational Status  
       Secondary and above (ref) 
  
6.612 2 .037
*
 
   
       No formal Education  1.616 .762 4.491 1 .034
*
 5.032 1.129 22.423 
       Primary .213 .858 .061 1 .804 1.237 .230 6.646 
Alcohol consumption 
Yes (ref) 
        
 No -1.225 .623 3.873 1 .049
*
 .294 .087 .995 
Tobaco and chat Use 
 Yes (ref) 
        
 No -2.296 .646 12.633 1 .000
*
 .101 .028 .357 
Baseline weight -.084 .042 4.019 1 .045
*
 .920 .847 .998 
Current weight -.074 .034 4.900 1 .027
*
 .928 .869 .992 
Baseline CD4 cell count  -.010 .003 7.895 1 .005
*
 .990 .984 .997 
Baseline lymphocyte count -.035 .023 2.296 1 .130 .966 .924 1.010 
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Baseline hemoglobin -.224 .066 11.400 1 .001
*
 .800 .702 .910 
TB_History 
 Yes (ref) 
        
 No -1.932 .703 7.552 1 .006
*
 .145 .037 .575 
Key: * Significant (p-value < 0.05), df: degree of freedom, ref: reference category, AHR: Adjusted Hazard Ratio 
Family size was the other significant predictor of survival time of patients. The hazard of death 
of HIV/AIDS patient treated under ART whose family size was one to two was 0.165 times less 
likely as compared to a patient having five or more family size (HR = 0.165, 95% CI: 0.051, 
0.545). The hazard of death was 88% less for patients having three to four families than those 
patients having five or more patients (HR = 0.120, 95% CI: 0.023, 0.637).  
The probability of death for illiterate HIV/AIDS patients on ART follow-up was 5.032 times 
higher than patients whose educational status was secondary or above (HR = 5.032, 95% CI: 
1.129, 22.423).  
HIV/AIDS patient who did not consume alcohol was 0.294 times less likely to be at risk of death 
than those patients who drink alcohol (HR = 0.294, 95% CI: 0.087, 0.995). The hazard of death 
for patient who did not use tobacco and chat was 89.1% less than a patient who used tobacco and 
chat (HR = 0.101, 95% CI: 0.028, 0.357). 
Baseline weight had also an association with the survival time of HIV patients. As baseline 
weight increased by one kilogram, the hazard of death of a patient decreased by 8% (HR = 0.920, 
95% CI: 0.847, 0.998).  The probability of death of a patient was also 7.2% less for one kilogram 
increase in current weight (HR = 0.928, 95% CI: 0.869, 0.992).   
A 1cell/µl increase in baseline CD4 cell count can decrease the hazard of a patient by 1% (HR = 
0.990, 95% CI: 0.984, 0.997). The risk of death of an HIV patient decreased by 20% as baseline 
hemoglobin increased by 1 g/dl (HR = 0.800, 95% CI: 0.702, 0.910). 
Compared with TB history, HIV patients with negative TB history had 85.5% reduced risk of 
death than the patients with positive TB history (HR = 0.145, 95% CI: 0.037, 0.575).  
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5. Discussion  
This study used the Classical techniques to analyze risk factors for the survival time of 
HIV/AIDS patients under ART follow-up. A number of variables were used to explain the 
variation in the survival time of HIV patients using the Cox Proportional Hazards Model. 
This Study found that 5.91% of the patients were died. This death rate was very small as 
compared to other similar studies (6, 8, 9, 10). The reason for this low figure reported may be 
due to good adherence level of patients to ART in the study area.  
Age of the patient was significantly associated with the survival time of HIV patient. Older aged 
patients had smaller survival probability as compared to younger age. This result also coincides 
with previous studied in Ethiopia by (6, 9), and in Brazil by (10). This may be due to that the 
immune recovery of older ages became decreased. 
In this study, the association of gender with survival experience was found not to be significant. 
Past studies by (5, 11, 12) also found the same result. The number of family members within the 
patient had a contribution for the survival time of the patient. In this study, we found that one to 
two family sized patients survived for long time as compared to the patients with large family 
(specifically, five or more). If more dependents and non fertile aged people in a limited economy 
were in the household, then it may be difficult to provide balanced and timely diet for the patient. 
So, the result may be happened due to this clue.  
Educational status was also a statistically significant predictor of the survival of patients. 
Illiterate patients had lower survival experience than the patients with primary or above 
educational level. This result was similar to the findings of (10, 13). This figure probably 
happened due to lack of the psychological, mental, healthcare and economic preparedness of less 
educated patients. 
Alcohol consumption, chat and tobacco usage were another influential covariates for the survival 
of patients. Drinking alcohol, tobacco and chat usage or taking other drugs can affect your 
immune system and may speed up the progression of the disease. Drinking or taking drugs also 
can affect your HIV treatment adherence.  
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The variables baseline and current weights had a statistically significant effect on the chance of 
survival of AIDS patients. The result of this study was consistent with the finding of other 
studies (6, 9). 
In this study, we found that baseline CD4 cell count determined the survival time of patients. 
Patients with lower CD4 cell count had lower survival experience. This study coincided with 
other similar studies (10, 13). CD4+ count is a major biological marker of immune status (14, 15 
16) and an indicator of late diagnosis and untimely treatment. Currently international consensus 
recommendations for treatment initiation are based on CD4+ counts, viral loads and clinical data 
(17, 18). 
This study also found that survival time was statistically associated with baseline hemoglobin. 
The study results indicated an association between positive TB status (patients with TB) and 
lower survival, which corroborates the finding of other study (13). 
6. Conclusions 
In this study we found very lower death cases as compared to many similar past studies. Results 
revealed that the variables age, family size, educational status, alcohol consumption, tobacco and 
chat usage, baseline weight, current weight, baseline CD4 cell count, baseline lymphocyte count, 
baseline hemoglobin and TB history were significantly associated with the survival experience of 
HIV patients under ART fellow-up. 
7. Recommendation 
We found that alcohol consumption had a significant effect on the survival time of HIV/AIDS 
patients. And we have seen that high number of patient were alcohol consumers. So, we 
recommend patients to abstain from choosing alcohol consumption. Clinicians and health 
workers must teach patient and create awareness on the terribleness of alcohol consumption to 
their survival.  
Weight also plays a crucial role on the survival of patients. Therefore, patients need to eat 
balanced diets that help from weight loss. And balancing the size of the family would greatly 
reduce the hazard of death of patients.  
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